Psoriasis
From the Journals
Chronic Back Pain in Patients With Psoriasis, Uveitis, or Colitis: How Often Is It Axial Spondyloarthritis?
A substantial proportion of patients with psoriasis, uveitis, or colitis and undiagnosed chronic back pain had axial spondyloarthritis, a study...
From the Journals
US Experience With Infliximab Biosimilars Suggests Need for More Development Incentives
Use of infliximab biosimilars in the United States rose slowly until three were on the market; it continued to remain lower for Medicare than for...
Feature
Light Therapy, Phototherapy, Photobiomodulation: New Ways to Heal With Light
New research is finding that different colors and wavelengths of light can treat conditions like chronic pain and vision loss.
Latest News
Management, Evaluation of Chronic Itch in Older Adults
A malignancy workup should be strongly considered in patients whose itch duration is less than 12 months -- and especially if the duration is less...
Latest News
Advantages of a Pediatric Rheumatology/Dermatology Clinic Evaluated
The top four primary diagnoses at the clinic were linear morphea (33%), lupus (23%), ...
Latest News
Study Finds Differences in Side Effect Profiles With Two Oral Psoriasis Therapies
The results were based on data from the FDA’s Adverse Event Reporting System.
Latest News
Risk of MACE Comparable Among Biologic Classes for Psoriasis, PsA
Despite some concern about increased risk for MACE with TNFi use, this study suggests no special risk for patients with psoriasis or PsA...
Latest News
Mysteries Persist About Tissue Resident Memory T Cells in Psoriasis
These cells reside in the skin and other tissues and promote the inflammatory response, likely contributing to psoriasis symptoms.
Latest News
Debate: Should Dermatologists or Rheumatologists Manage Musculoskeletal Symptoms in Patients With Psoriasis?
The rheumatologist emphasized the potential that MSK symptoms are a sign of psoriatic arthritis and therefore should be managed by a...
News from the FDA/CDC
Pyzchiva Receives FDA Approval as Third Ustekinumab Biosimilar
The biosimilar is approved for all indications of the reference medication, Stelara, and will launch in February 2025.
Practical Pearls
Need a Wood Lamp Alternative? Grab Your Smartphone
Free smartphone applications (apps) can simulate UV light and functionally serve as a Wood lamp.